Cross Country Healthcare (CCRN) The 44th Annual William Blair Growth Stock Conference summary
Event summary combining transcript, slides, and related documents.
The 44th Annual William Blair Growth Stock Conference summary
31 Jan, 2026Company overview and technology strategy
Focuses on tech-enabled workforce solutions, leveraging business intelligence and machine learning to address complex labor challenges in healthcare and education sectors.
Offers a comprehensive technology stack, including the Xperience app for clinicians and Intellify for workforce management.
Invests $20–$30 million annually in technology to maintain a high-tech, high-touch approach.
Emphasizes seamless integration of people, processes, and technology to optimize staffing and improve patient outcomes.
Strong financial position with no debt and over $200 million in available capital, supporting ongoing investment and M&A.
Industry trends and market analysis
Healthcare faces a persistent nurse shortage, projected between 400,000 and 1 million by 2035, driven by retiring nurses, limited nursing school capacity, and burnout.
The supply-demand imbalance is expected to persist long-term, with current job openings to hires ratio at 1.9:1, above pre-pandemic levels.
Hospitals have overcorrected on contract labor, leading to understaffing and potential patient safety risks.
Demand for travel nurses is stabilizing, with expectations for cyclical increases in the second half of the year.
Decision-making for contract labor is shifting back from CFOs to clinical leaders as spending normalizes.
Product innovation and client solutions
Xperience app uses AI to match clinicians with assignments, streamlining recruitment and retention while supporting clinicians with a high-touch model.
Intellify, a proprietary vendor management system, provides real-time analytics, workforce optimization, and cost savings for healthcare clients.
DaaS platform delivers transparent, real-time labor market data, enabling informed staffing decisions and bill rate validation.
Technology investments have doubled the addressable market, enabling entry into vendor-neutral and VMS spaces.
Vendor-neutral offerings are expected to capture up to $1 billion in spend under management, with high-margin, SaaS-like profitability.
Latest events from Cross Country Healthcare
- 2025 saw revenue and profit declines, but 2026 is set for sequential growth and margin gains.CCRN
Q4 20255 Mar 2026 - Q2 revenue fell 37% to $339.8M, with net loss of $16.1M but strong cash flow and tech gains.CCRN
Q2 20242 Feb 2026 - Staffing demand stabilizes as technology, vendor-neutral growth, and margin focus drive expansion.CCRN
Jefferies Global Healthcare Conference1 Feb 2026 - Q3 2024 revenue dropped 29% year-over-year, with margin pressure and mixed segment trends.CCRN
Q3 202416 Jan 2026 - Shareholders to vote on a $18.61/share cash merger, with board unanimous support and appraisal rights.CCRN
Proxy Filing1 Dec 2025 - Acquisition by Aya Healthcare announced, pending shareholder approval and regulatory review.CCRN
Proxy Filing1 Dec 2025 - Stockholders to receive $18.61 per share in cash in a board-approved merger, with a 67% premium.CCRN
Proxy Filing1 Dec 2025 - Aya to acquire Cross Country Healthcare for $18.61/share in a $615M all-cash merger.CCRN
Proxy Filing1 Dec 2025 - Cross Country to be acquired by Aya Healthcare, pending shareholder approval and regulatory review.CCRN
Proxy Filing1 Dec 2025